BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15055821)

  • 1. Six-months of recombinant human GH therapy in patients with ischemic cardiac failure.
    van Thiel SW; Smit JW; de Roos A; Bax JJ; van der Wall EE; Biermasz NR; Viergever E; Vliegen HW; Romijn JA; Roelfsema F; Lamb HJ
    Int J Cardiovasc Imaging; 2004 Feb; 20(1):53-60. PubMed ID: 15055821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass.
    Smit JW; Janssen YJ; Lamb HJ; van der Wall EE; Stokkel MP; Viergever E; Biermasz NR; Bax JJ; Vliegen HW; de Roos A; Romijn JA; Roelfsema F
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4638-43. PubMed ID: 11600518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
    McElhinney DB; Colan SD; Moran AM; Wypij D; Lin M; Majzoub JA; Crawford EC; Bartlett JM; McGrath EA; Newburger JW
    Pediatrics; 2004 Oct; 114(4):e452-8. PubMed ID: 15466071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration.
    Osterziel KJ; Blum WF; Strohm O; Dietz R
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1533-9. PubMed ID: 10770193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function.
    Osterziel KJ; Ranke MB; Strohm O; Dietz R
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):61-8. PubMed ID: 10931081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
    Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
    Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity.
    Genth-Zotz S; Zotz R; Geil S; Voigtländer T; Meyer J; Darius H
    Circulation; 1999 Jan 5-12; 99(1):18-21. PubMed ID: 9884373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment in dilated cardiomyopathy.
    Perrot A; Ranke MB; Dietz R; Osterziel KJ
    J Card Surg; 2001; 16(2):127-31. PubMed ID: 11766830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of terminal dilated cardiomyopathy with growth hormone].
    Dreifuss P
    Z Kardiol; 1998 Jun; 87(6):425-35. PubMed ID: 9691412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure.
    Giustina A; Volterrani M; Manelli F; Desenzani P; Poiesi C; Lorusso R; Giordano A
    Am Heart J; 1999 Jun; 137(6):1035-43. PubMed ID: 10347328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.
    Ezzat S; Fear S; Gaillard RC; Gayle C; Landy H; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2725-33. PubMed ID: 12050241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone improves cardiac function in rats with experimental myocardial infarction.
    Isgaard J; Kujacic V; Jennische E; Holmäng A; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA
    Eur J Clin Invest; 1997 Jun; 27(6):517-25. PubMed ID: 9229233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration among Heart Failure Patients Four Weeks after Myocardial Infarction: A Randomized Double-Blinded Clinical Trial.
    Amirpour A; Vakhshoori M; Zavar R; Zarei H; Sadeghi M; Yavari B
    Cardiovasc Ther; 2021; 2021():2680107. PubMed ID: 33552234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.